Opiate-free anaesthesia may cut need for pain-killers

Image
Press Trust of India London
Last Updated : May 30 2016 | 6:08 PM IST
Patients undergoing breast cancer surgery need less painkilling medication post-surgery if they have anaesthesia that is free of opioid drugs, researchers have found.
While opioid drugs provide an excellent painkilling effect throughout operations, they also have side-effects, researchers said.
Post-operative complications, such as respiratory depression, post-operative nausea and vomiting, itching, difficulty going to the toilet and bowel obstruction are well known examples of such side-effects, they said.
"Our results show that patients in the non-opiate group require less painkillers, but receive adequate pain relief. Patients require less analgesics 24 hours after a non-opiate anaesthesia than after an opiate anaesthesia," said Sarah Saxena from Jules Bordet Institute in Belgium.
For the study which took place between 2014 and 2015, researchers examined painkiller requirements after patients received opiate anaesthesia and non-opiate anaesthesia.
A randomised controlled trial was conducted, containing two groups each with 33 breast cancer patients undergoing a mastectomy or lumpectomy.
Perioperative non-opiate analgesia was obtained by combining clonidine, ketamine and lidocaine, researchers said.
An extra bolus of ketamine was given if necessary. Opiate analgesia was obtained via a combination of remifentanil infusion, ketamine and lidocaine, they said.
Both groups received intravenous paracetamol and intravenous diclofenac. Patients received a PCA (patient-controlled analgesia) pump for breakthrough pain during the first 24 hours post-operatively.
Clinical characteristics and post-operative piritramide painkiller consumption through the patient controlled pump were assessed during the first 24 hours post-operatively.
The total mean piritramide usage 24 hours post-operatively was 8.1 milligrammes (range 2.0-14.5) in the non-opiate group and 13.1 milligrammes (range 6.0-16.0) in the opioid group. The difference observed was statistically significant, researchers said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 30 2016 | 6:08 PM IST

Next Story